The FDA approved mFlusiva to help prevent the flu in adults ages 50 and older. The flu is a viral infection that affects the lungs and breathing airways. It causes a fever, body aches, and… Read more
The FDA has approved Tudriqev (vusolimogene oderparepvec-wtpg) to treat adults with advanced skin cancer called cutaneous melanoma. It is used for cancer that cannot be removed by surgery and has gotten worse after treatment with… Read more
The FDA has approved Orzeyful (oveporexton) for adults with a long-term sleep disorder called narcolepsy type 1. People with this condition have extreme sleepiness during the day and a hard time focusing or staying awake.… Read more
The FDA has approved Zenbexus (iberdomide) to treat adults with multiple myeloma. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It is used for people whose cancer… Read more
The FDA has approved Pasatru (garetosmab) for adults with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare genetic disease. It causes muscles, tendons, and ligaments to gradually turn into bone outside the normal skeleton. Over… Read more
Genglycos (pariglasgene brecaparvovec) is FDA approved for adults and children 8 and older who have glycogen storage disease type 1a (GSD1a). GSD1a is a rare genetic disorder caused by a missing enzyme called glucose-6-phosphatase (G6Pase).… Read more
The FDA has approved Ziihera (zanidatamab-hrii) to treat adults with advanced or spreading gastroesophageal adenocarcinoma (GEA). GEA includes cancers of the stomach, the esophagus, and the area where the stomach and esophagus meet. This drug… Read more
The FDA has approved Imaavy (nipocalimab-aahu) to treat adults and children 12 and older who have warm autoimmune hemolytic anemia (wAIHA). It is for people who are taking or have taken steroid medicines for their… Read more
The FDA has approved Rasonque (daraxonrasib) to treat adults with advanced pancreatic cancer. The drug is for people with pancreatic adenocarcinoma that has spread to other parts of the body. It is used when patients… Read more
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, a rare autoimmune disease. It causes the body’s immune system to attack its own muscles and skin. People with this condition often suffer from… Read more